Sanofi bought LTGO
August 10, 2026 · Form 4 insider transaction
Sanofi bought 494,800 shares of LTGO, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
494,800
Price
N/A
Total value
N/A
InsiderSanofi
Role10% owner
CompanyLTGO
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateAugust 10, 2026
Filing dateAugust 12, 2026
Shares owned after494,800
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The Series B Convertible Preferred Stock (the "Preferred Stock") converted automatically into shares of common stock on a one-for-one basis upon the closing of the Issuer's initial public offering on August 10, 2026 (the "IPO") without payment of consideration.; Sanofi beneficially owns the securities reported herein through various wholly-owned subsidiaries.